https://scholars.lib.ntu.edu.tw/handle/123456789/581803
Title: | Quantification of Hepatitis B Core Antibody Helps Predict Clinical Relapse After Cessation of Nucleos(t)ide Analogues in Chronic Hepatitis B Patients: More Needs to Be Done | Authors: | Hsu Y.-C. Tseng C.-H. JIA-HORNG KAO |
Issue Date: | 2019 | Publisher: | W.B. Saunders | Journal Volume: | 17 | Journal Issue: | 5 | Start page/Pages: | 1000-1001 | Source: | Clinical Gastroenterology and Hepatology | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85062943526&doi=10.1016%2fj.cgh.2018.09.002&partnerID=40&md5=8e5861fa5b6f270bb27953aa9512b62e https://scholars.lib.ntu.edu.tw/handle/123456789/581803 |
ISSN: | 1542-3565 | DOI: | 10.1016/j.cgh.2018.09.002 | SDG/Keyword: | adefovir; aminotransferase; circular DNA; entecavir; hepatitis B core antibody; lamivudine; nucleoside analog; telbivudine; tenofovir; hepatitis B antibody; hepatitis B(e) antigen; age distribution; algorithm; aminotransferase blood level; antibody blood level; chronic hepatitis B; clinical assessment; disease duration; drug withdrawal; evidence based practice; human; infection risk; Letter; low risk patient; practice guideline; recurrence risk; sample size; virus reactivation; chronic hepatitis B; recurrent disease; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Recurrence |
Appears in Collections: | 臨床醫學研究所 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.